Enanta Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:ENTA) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 14.78 M10.4 M16.8 M13.49 M-17.51 M6.49 M11.7 M 14.17 M Cash from investing activities -6.34 M19.07 M68.9 M-4.37 M-26.48 M2.3 M47.3 M 18.74 M Cash from financing activities 6.65 M7.21 M4.99 M6.89 M6.42 M8.32 M64.14 M 85.77 M Free cash flow 8.23 M1.45 M8.06 M10.95 M-17.66 M5.03 M11.56 M 9.88 M

뉴스

What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

Enanta earnings beat by $0.39, revenue topped estimates

Enanta Pharmaceuticals, Inc. (ENTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

베어드, 엔안타 제약에 ’시장수익률 상회’ 투자의견 재확인

Baird reiterates Outperform rating on Enanta Pharmaceuticals stock

Enanta, RSV 및 면역학 파이프라인 진전

Enanta advances RSV and immunology pipeline with key milestones ahead

Agios Pharmaceuticals (AGIO) Surges 18.6%: Is This an Indication of Further Gains?

Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains?

Enanta Pharma CSO Or Yat Sun sells $34k in stock

Enanta Pharma CBO Luu sells $19,836 in stock